Global Maritime Analytics Market Analysis Report 2024-2028: The Rising Popularity of Marine Tourism – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Maritime Analytics Market: Analysis By Application, By End User, By Region Size, Trends and Forecast to 2028”... Read more.
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
Application based on results from the TROPION-Lung01 Phase III trial If approved, AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan may be the first TROP2-directed... Read more.
TAGRISSO® (osimertinib) demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial
First EGFR inhibitor and targeted treatment to demonstrate progression-free survival benefit in Stage III setting WILMINGTON, Del.–(BUSINESS WIRE)–Positive... Read more.
Pulsate Raises $7.75M in Series A Funding Backed By TruStage Ventures and Curql
DUBLIN–(BUSINESS WIRE)–In response to continued demand for better consumer engagement tools for the digital channel, Pulsate, provider of mobile-first... Read more.
Pulsate Raises $7.75M in Series A Funding Backed By TruStage Ventures and Curql
DUBLIN–(BUSINESS WIRE)–In response to continued demand for better consumer engagement tools for the digital channel, Pulsate, provider of mobile-first... Read more.
Fluor to Participate in Upcoming Investor Conferences
IRVING, Texas–(BUSINESS WIRE)–Fluor Corporation (NYSE: FLR) today announced that Jason Landkamer, Executive Director- Investor Relations will be hosting... Read more.
NEC and D-Wave Introduce New Quantum Offerings to Australian Market
SYDNEY & PALO ALTO, Calif. & BURNABY, British Columbia–(BUSINESS WIRE)–NEC Australia and leading international quantum computing company, D-Wave... Read more.
STAAR Surgical to Report Fourth Quarter Results on February 26, 2024
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable... Read more.
Fiserv Appoints Lance Fritz to Board of Directors
BROOKFIELD, Wis.–(BUSINESS WIRE)–Fiserv, Inc. (NYSE: FI), a leading global provider of payments and financial services technology, today announced the... Read more.
Antimicrobial Resistance Diagnostic Markets Transforming Global Healthcare with Innovative Technologies and Trends 2023-2027 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides... Read more.